Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9051-9100 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05326347
A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
PHASE3Active, not recruiting
190 participants
Started: May 31, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05144789
Personalized Therapeutic Neuromodulation for Anhedonic Depression
NAActive, not recruiting
79 participants
Started: May 31, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05404009
Collecting Dietary Information From People Undergoing Cancer Treatment
N/AActive, not recruiting
150 participants
Started: May 31, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05173896
Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial
PHASE2Active, not recruiting
100 participants
Started: May 31, 2022 · Completed: Dec 31, 2029
2 conditions7 sponsors2 locations
NCT05258539
Breast Cancer Prevention and Screening Membership
NAActive, not recruiting
189 participants
Started: May 31, 2022 · Completed: Apr 1, 2032
1 condition1 sponsor1 location
NCT05163249
Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC
PHASE2Active, not recruiting
44 participants
Started: May 31, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05162391
Inflammation in Methamphetamine and STIs (IMSTI)
NAActive, not recruiting
30 participants
Started: May 31, 2022 · Completed: Jun 30, 2027
3 conditions1 sponsor1 location
NCT05030155
Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients with Eosinophilic Granulomatosis with Polyangiitis (E-merge)
PHASE3Active, not recruiting
100 participants
Started: May 30, 2022 · Completed: Nov 30, 2025
1 condition3 sponsors1 location
NCT05335018
GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma
PHASE2Active, not recruiting
76 participants
Started: May 30, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05186974
Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
PHASE2Active, not recruiting
193 participants
Started: May 30, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors101 locations
NCT05257577
Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO)
N/AActive, not recruiting
220 participants
Started: May 28, 2022 · Completed: Mar 30, 2027
6 conditions4 sponsors4 locations
NCT05319808
Rehabilitation for Whiplash Associated Disorders
NAActive, not recruiting
180 participants
Started: May 27, 2022 · Completed: Apr 30, 2024
1 condition4 sponsors4 locations
NCT05300477
Pharmacological Countermeasures for High Altitude
PHASE4Active, not recruiting
18 participants
Started: May 27, 2022 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05174767
PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
NAActive, not recruiting
115 participants
Started: May 27, 2022 · Completed: Dec 6, 2029
1 condition2 sponsors25 locations
NCT05297890
A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
70 participants
Started: May 27, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors31 locations
NCT05281744
Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias
NAActive, not recruiting
2,160 participants
Started: May 27, 2022 · Completed: Mar 1, 2026
1 condition3 sponsors1 location
NCT05879068
A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC
PHASE2Active, not recruiting
99 participants
Started: May 27, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor11 locations
NCT05300724
An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
N/AActive, not recruiting
400 participants
Started: May 27, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor75 locations
NCT04637594
Trying to Find the Correct Length of Treatment with Immune Checkpoint Therapy
PHASE3Active, not recruiting
3 participants
Started: May 27, 2022 · Completed: Sep 30, 2030
10 conditions2 sponsors377 locations
NCT05251714
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer
PHASE1/PHASE2Active, not recruiting
44 participants
Started: May 27, 2022 · Completed: Aug 31, 2026
2 conditions1 sponsor4 locations
NCT05345444
Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)
NAActive, not recruiting
48 participants
Started: May 26, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05317689
Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
PHASE1Active, not recruiting
20 participants
Started: May 26, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05138250
A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by Mepolizumab In COPD
PHASE3Active, not recruiting
32 participants
Started: May 26, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05421689
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
PHASE1/PHASE2Active, not recruiting
66 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors2 locations
NCT05441722
CIPN in Early Stage Breast Cancer Patients
NAActive, not recruiting
48 participants
Started: May 26, 2022 · Completed: Jul 1, 2024
2 conditions4 sponsors1 location
NCT05763940
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
NAActive, not recruiting
130 participants
Started: May 25, 2022 · Completed: Jun 25, 2024
3 conditions2 sponsors1 location
NCT05387473
Added Value of Cognitive Behavioural Therapy for Insomnia in Persons With Knee Osteoarthritis
NAActive, not recruiting
128 participants
Started: May 25, 2022 · Completed: Nov 30, 2026
2 conditions3 sponsors1 location
NCT05778032
Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS)
N/AActive, not recruiting
30 participants
Started: May 25, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05144087
The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
N/AActive, not recruiting
18 participants
Started: May 25, 2022 · Completed: Nov 30, 2027
1 condition3 sponsors1 location
NCT06866301
Active Lifestyle Intervention in Anorexia Nervosa: a Comprehensive Study
NAActive, not recruiting
48 participants
Started: May 25, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04968015
Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission
PHASE2Active, not recruiting
134 participants
Started: May 25, 2022 · Completed: Jan 31, 2029
1 condition1 sponsor26 locations
NCT05967169
EFS of Bioabsorbable Implant for NSD
NAActive, not recruiting
30 participants
Started: May 25, 2022 · Completed: Dec 8, 2025
1 condition1 sponsor2 locations
NCT05338775
A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma
PHASE1Active, not recruiting
74 participants
Started: May 25, 2022 · Completed: May 3, 2027
1 condition1 sponsor19 locations
NCT05199584
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
PHASE2Active, not recruiting
44 participants
Started: May 24, 2022 · Completed: May 31, 2024
1 condition1 sponsor16 locations
NCT05397223
A Study of Modified mRNA Vaccines in Healthy Adults
PHASE1Active, not recruiting
308 participants
Started: May 24, 2022 · Completed: Feb 21, 2026
4 conditions1 sponsor8 locations
NCT05318300
Evaluation of an Adapted Formula on Atopic Dermatitis.
NAActive, not recruiting
126 participants
Started: May 24, 2022 · Completed: Apr 30, 2024
1 condition1 sponsor3 locations
NCT05163158
CENtral Blood Pressure Targeting: a Pragmatic RAndomized Pilot TriaL in Advanced Chronic Kidney Disease
NAActive, not recruiting
116 participants
Started: May 24, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05252195
Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS)
N/AActive, not recruiting
300 participants
Started: May 24, 2022 · Completed: Mar 31, 2027
1 condition4 sponsors3 locations
NCT06157567
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
NAActive, not recruiting
500 participants
Started: May 24, 2022 · Completed: May 24, 2028
3 conditions1 sponsor6 locations
NCT05462041
DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors
NAActive, not recruiting
30 participants
Started: May 24, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05039203
Bacteriuria and Indwelling Urinary Catheter.
N/AActive, not recruiting
196 participants
Started: May 24, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor2 locations
NCT06190015
Impact of Advanced Platelet Rich Fibrin and Enamel Matrix Derivative on Clinical and Molecular Wound Healing Parameters After Surgical Removal of Mandibular Third Molars
PHASE4Active, not recruiting
120 participants
Started: May 23, 2022 · Completed: Mar 20, 2024
2 conditions1 sponsor1 location
NCT05389436
Outpatient Versus Inpatient Surgery for Ankle Fractures
NAActive, not recruiting
86 participants
Started: May 23, 2022 · Completed: May 31, 2026
4 conditions1 sponsor1 location
NCT05426486
A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients
PHASE2/PHASE3Active, not recruiting
136 participants
Started: May 23, 2022 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT05416424
Life Study: Lifestyle Intervention in Fibroid Elimination
NAActive, not recruiting
100 participants
Started: May 23, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05910385
TUbal LIgation Per Differents Endoscopic Routes and Sexuality (TULIPES)
NAActive, not recruiting
140 participants
Started: May 23, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor2 locations
NCT05236439
Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma
NAActive, not recruiting
57 participants
Started: May 23, 2022 · Completed: Dec 15, 2025
2 conditions2 sponsors1 location
NCT06680362
The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery
N/AActive, not recruiting
176 participants
Started: May 22, 2022 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05472402
Feasibility and Acceptability of an Online Program to Promote Physical Activity Among Black Women
NAActive, not recruiting
60 participants
Started: May 22, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT04342715
A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis
N/AActive, not recruiting
216 participants
Started: May 22, 2022 · Completed: Mar 31, 2026
1 condition7 sponsors1 location